AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
High-dose intravenous vitamin C has shown potential in selectively killing cancer cells in live patients and saving sepsis patients from dying. However, it acts as a pro-oxidant in cancer, requiring separation from glutathione. This delicate balance is crucial, as it needs to be avoided when killing cancer but maintained for overall health. Doses as low as 2000 milligrams of vitamin C per day can raise oxalate levels in most people, while even as little as 400 milligrams may raise oxalate in some individuals. Achieving the right balance between the dose, individual factors, and context is essential.